DS-21360717

N/A

Report date: 2023/04/20 09:43:34
NME

Base Information

Drug NameDS-21360717
Drug Alias NameDS-21360717
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFER Tyrosine Kinase inhibitors
TargetsFER Tyrosine Kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A